(a) Shipping
non-creditable subpart P hazardous waste or evaluated hazardous waste
pharmaceuticals. A healthcare facility or electronic nicotine delivery system
retailer must ship non-creditable subpart P hazardous waste and a reverse
distributor must ship evaluated hazardous waste pharmaceuticals off-site to a
designated facility (such as a permitted or interim status treatment, storage,
or disposal facility) in compliance with:
(1)
The following pre-transport requirements, before transporting or offering for
transport off-site:
(i) Packaging. Package the
waste in accordance with the applicable Department of Transportation
regulations on hazardous materials under 49 CFR parts
173,
178, and
180.
(ii) Labeling. Label each package
in accordance with the applicable Department of Transportation regulations on
hazardous materials under 49 CFR part
172 subpart E.
(iii) Marking.
(A) Mark each package of hazardous waste
pharmaceuticals or hazardous waste electronic nicotine delivery systems in
accordance with the applicable Department of Transportation (DOT) regulations
on hazardous materials under 49 CFR part
172 subpart D;
(B) Mark each container of 119 gallons or
less used in such transportation with the following words and information in
accordance with the requirements of
49 CFR
172.304:
HAZARDOUS WASTE-Federal Law Prohibits Improper Disposal.
If found, contact the nearest police or public safety authority or the U.S.
Environmental Protection Agency.
Healthcare facility's, Electronic nicotine delivery
system retailer's, or
Reverse distributor's Name and Address ___________
Healthcare facility's, Electronic nicotine delivery
system retailer's, or
Reverse distributor's EPA Identification Number
___________
Manifest Tracking Number ___________
(C) Lab packs that will be incinerated in
compliance with § 268.42(c) are not required to be marked with EPA
Hazardous Waste Number(s), except D004, D005, D006, D007, D008, D010, and D011,
where applicable. A nationally recognized electronic system, such as bar coding
or radio frequency identification, may be used to identify the EPA Hazardous
Waste Number(s).
(iv)
Placarding. Placard or offer the initial transporter the appropriate placards
according to Department of Transportation regulations for hazardous materials
under 49 CFR part
172 subpart F.
(2) The manifest requirements of 40 CFR part
262 subpart B, except that:
(i) A healthcare
facility shipping non-creditable hazardous waste pharmaceuticals is not
required to list all applicable hazardous waste numbers (i.e., hazardous waste
codes) in Item 13 of EPA Form 8700-22.
(ii) A healthcare facility shipping
non-creditable hazardous waste pharmaceuticals must write either the code
"PHARMS" or the code "PHRM" in Item 13 of EPA Form 8700-22.
(b) Exporting
non-creditable subpart P hazardous waste or evaluated hazardous waste
pharmaceuticals. A healthcare facility, electronic nicotine delivery system
retailer, or reverse distributor that exports non-creditable subpart P
hazardous waste or evaluated hazardous waste pharmaceuticals is subject to 40
CFR part
262 subpart H.
(c)
Importing non-creditable subpart P hazardous waste or evaluated hazardous waste
pharmaceuticals. Any person that imports non-creditable subpart P hazardous
waste or evaluated hazardous waste pharmaceuticals is subject to 40 CFR part
262 subpart H. A healthcare facility, electronic nicotine delivery system
retailer, or reverse distributor may not accept imported non-creditable subpart
P hazardous waste or evaluated hazardous waste pharmaceuticals unless they have
a permit or interim status that allows them to accept hazardous waste from off
site.
Notes
Haw. Code R. §§
11-266.508
[Eff
6/25/2020] (Auth: HRS §§
342J-4,
342J-31,
342J-32,
342J-33,
342J-34,
342J-34.5,
342J-35) (Imp: HRS
§§
342J-4,
342J-31,
342J-32,
342J-33,
342J-34,
342J-34.5,
342J-35)
Am
and comp 6/7/2021
Am
and comp 1/29/2024